Read this company snapshot
Daily valuation snapshot
Bone Biologics Corp Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.47
- Market capitalization (USD)
- $1,287,354.22
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.33
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BBLG in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BBLG in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BBLG with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.47 |
| Market capitalization (USD) | $1,287,354.22 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.33 |
No matching rows. Clear the filter to see all records.
Read BBLG's valuation metrics
Company size
Bone Biologics Corp Common Stock's recorded market capitalization is $1,287,354.22. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
BBLG's recorded price-to-book ratio is 0.33. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Bone Biologics Corp Common Stock with Aurora
Use the snapshot above to ask a specific question about BBLG. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow BBLG's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.